1. Home
  2. KZIA vs DH Comparison

KZIA vs DH Comparison

Compare KZIA & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

SELL

Current Price

$5.61

Market Cap

125.6M

Sector

Health Care

ML Signal

SELL

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

SELL

Current Price

$1.26

Market Cap

137.2M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
KZIA
DH
Founded
1994
2011
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
137.2M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
KZIA
DH
Price
$5.61
$1.26
Analyst Decision
Strong Buy
Hold
Analyst Count
9
6
Target Price
★ $28.76
$1.63
AVG Volume (30 Days)
167.6K
★ 450.9K
Earning Date
11-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 63.28
EPS
★ N/A
N/A
Revenue
N/A
★ $241,521,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.86
$0.61
52 Week High
$17.40
$3.00

Technical Indicators

Market Signals
Indicator
KZIA
DH
Relative Strength Index (RSI) 26.35 61.99
Support Level $4.86 $1.03
Resistance Level $14.85 N/A
Average True Range (ATR) 0.68 0.08
MACD -0.10 0.01
Stochastic Oscillator 2.75 55.41

Price Performance

Historical Comparison
KZIA
DH

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: